journal article·2024-08Open access

When Mechanical Stress Matters: Generation of Polyploid Giant Cancer Cells in Tumor‐Like Microcapsules

Yasmin Antonelli, René Krüger, Adrian Buehler, Mahshid Monavari, Miguel Fuentes‐Chandía, Federico Colombo, Ralf Palmisano, Anja K. Boßerhoff, Melanie Kappelmann‐Fenzl, Johannes Schödel, Aldo R. Boccaccini, Christine Selhuber‐Unkel, Gaelle Letort, Aldo Leal‐Egaña

Advanced Functional Materials· Volume 34· Issue 35

Abstract

Abstract Biofabrication techniques enable the performance of bioinspired three‐dimensional (3D) matrices resembling primary tumors. To validate their reliability, embedded cells may express complex biophysical responses. Among others, the emergence of tumor heterogeneity and the generation of Polyploid Giant Cancer Cells (PGCC), as a result of the mechanical stress, are two of the most challenging hallmarks to resemble in vitro. Here, these phenomena are studied in cells cultured on two‐dimensional (2D) flasks, in 3D spheroids, or immobilized within 3D polymer‐based tumor‐like microcapsules. These results show that cells cultured in 3D microcapsules exhibited an enhanced biomechanical heterogeneity, a higher number of PGCC, and an increased exertion of cell‐matrix attachment forces with respect to the other two experimental conditions. Additionally, cells isolated from tumor‐like microcapsules redistribute and align the cytoplasmatic protein Caveolin‐1, and upregulate markers involved in cell proliferation (i.e., Ki67), metastasis (i.e., TGF‐β1, TGF‐β‐R2), and epithelial to mesenchymal transition, to name a few. These hallmarks are barely described in the past as a result of the confinement and mechanical stress. Thus, in this work it is demonstrated that both the mechanical stress and confinement are required to stimulate cell polyploidy and biomechanical heterogeneity, which can be easily addressed by immobilizing breast cancer cells in tumor‐like microcapsules.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cellular Mechanics and Interactions · 3D Printing in Biomedical Research · Cancer Cells and Metastasis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute for Molecular Systems Engineering and Advanced Materials (IMSEAM) Universität Heidelberg Im Neuenheimer Feld 225 69120 Heidelberg Germany

Department of Nephrology and Hypertension Universitätsklinikum Erlangen and Friedrich‐Alexander‐Uniklinikum Erlangen Ulmenweg 18 91054 Erlangen Germany

Institute of Biomaterials Friedrich‐Alexander Universität Erlangen‐Nürnberg Cauerstraße 6 91058 Erlangen Germany

Department of Biology Skeletal Research Center Case Western Reserve University Cleveland OH 10900 USA

Optical Imaging Competence Centre OICE Friedrich‐Alexander Universität Erlangen‐Nürnberg Cauerstraße 3 91058 Erlangen Germany

Institute of Biochemistry Emil‐Fischer‐Zentrum, Friedrich‐Alexander Universität Erlangen‐Nürnberg Fahrstraße 17 91054 Erlangen Germany

Faculty of Computer Science Deggendorf Institute of Technology 94469 Deggendorf Germany

Department of Developmental and Stem Cell Biology Institut Pasteur Université de Paris Cité CNRS UMR 3738, 25 rue du Dr. Roux Paris 75015 France

Funding

Deutsche Forschungsgemeinschaft · Bundesministerium für Bildung und Forschung · Volkswagen Foundation

References (100+)

Show source-provided references
1. 10.1038/s41467-020-18794-x10.1038/s41467-020-18794-x ↗
2. 10.1038/s41580-019-0172-910.1038/s41580-019-0172-9 ↗
3. 10.3389/fbioe.2021.66050210.3389/fbioe.2021.660502 ↗
4. 10.1038/s41467-022-29358-610.1038/s41467-022-29358-6 ↗
5. 10.1016/j.semcancer.2021.03.00310.1016/j.semcancer.2021.03.003 ↗
6. 10.3389/fonc.2021.55747710.3389/fonc.2021.557477 ↗
7. 10.1016/j.celrep.2021.10875010.1016/j.celrep.2021.108750 ↗
8. 10.3389/fendo.2019.0068210.3389/fendo.2019.00682 ↗
9. 10.3389/fbioe.2016.0001210.3389/fbioe.2016.00012 ↗
10. 10.1186/s12929-022-00866-310.1186/s12929-022-00866-3 ↗
11. 10.1002/adbi.20200034910.1002/adbi.202000349 ↗
12. 10.1016/j.actbio.2022.02.01010.1016/j.actbio.2022.02.010 ↗
13. 10.1016/j.semcancer.2021.03.01710.1016/j.semcancer.2021.03.017 ↗
14. 10.1016/j.semcancer.2021.05.01410.1016/j.semcancer.2021.05.014 ↗
15. 10.3389/fcell.2021.67634410.3389/fcell.2021.676344 ↗
16. 10.1016/j.drudis.2019.05.02410.1016/j.drudis.2019.05.024 ↗
17. 10.1016/j.anndiagpath.2017.11.00310.1016/j.anndiagpath.2017.11.003 ↗
18. 10.1016/j.prp.2017.11.00210.1016/j.prp.2017.11.002 ↗
19. Moein S. · Bioch. Biophys. Acta · 2021 · 1874
20. 10.3389/fcell.2021.80966810.3389/fcell.2021.809668 ↗
21. 10.3389/fonc.2020.56711610.3389/fonc.2020.567116 ↗
22. 10.3389/fcell.2019.0031110.3389/fcell.2019.00311 ↗
23. 10.3389/fonc.2021.72478110.3389/fonc.2021.724781 ↗
24. 10.1073/pnas.161229011310.1073/pnas.1612290113 ↗
25. 10.1038/s41598-018-29817-510.1038/s41598-018-29817-5 ↗
26. 10.1016/j.ebiom.2022.10405610.1016/j.ebiom.2022.104056 ↗
27. 10.1186/s12935-023-02971-110.1186/s12935-023-02971-1 ↗
28. 10.1002/1878-0261.1291310.1002/1878-0261.12913 ↗
29. 10.1002/adbi.20180030010.1002/adbi.201800300 ↗
30. 10.1126/sciadv.abc132310.1126/sciadv.abc1323 ↗
31. 10.1038/s41378-020-00201-610.1038/s41378-020-00201-6 ↗
32. 10.1021/acsami.6b0077810.1021/acsami.6b00778 ↗
33. 10.1002/adfm.20230235610.1002/adfm.202302356 ↗
34. 10.1002/jcp.2866510.1002/jcp.28665 ↗
35. 10.3389/fbioe.2019.0034310.3389/fbioe.2019.00343 ↗
36. 10.1002/adhm.20210062510.1002/adhm.202100625 ↗
37. 10.1002/adma.20190116610.1002/adma.201901166 ↗
38. 10.1002/adma.20190458010.1002/adma.201904580 ↗
39. 10.1016/j.tibtech.2019.08.00310.1016/j.tibtech.2019.08.003 ↗
40. 10.1007/s12668-016-0191-310.1007/s12668-016-0191-3 ↗
41. 10.1186/s13046-022-02328-y10.1186/s13046-022-02328-y ↗
42. 10.1016/j.ceb.2021.04.00110.1016/j.ceb.2021.04.001 ↗
43. 10.1016/j.actbio.2018.04.02810.1016/j.actbio.2018.04.028 ↗
44. 10.1021/acsbiomaterials.0c0153010.1021/acsbiomaterials.0c01530 ↗
45. 10.3389/fmedt.2022.90994310.3389/fmedt.2022.909943 ↗
46. 10.3389/fonc.2021.73365210.3389/fonc.2021.733652 ↗
47. 10.1016/j.addr.2021.04.00110.1016/j.addr.2021.04.001 ↗
48. 10.1002/biot.20190021710.1002/biot.201900217 ↗
49. 10.1007/s00330-019-06473-510.1007/s00330-019-06473-5 ↗
50. 10.1016/j.ultrasmedbio.2015.07.01310.1016/j.ultrasmedbio.2015.07.013 ↗
51. 10.1091/mbc.e16-10-069410.1091/mbc.e16-10-0694 ↗
52. 10.1016/bs.mcb.2014.10.00810.1016/bs.mcb.2014.10.008 ↗
53. 10.1016/j.micron.2021.10313810.1016/j.micron.2021.103138 ↗
54. 10.1039/C5IB00056D10.1039/C5IB00056D ↗
55. 10.15252/msb.20211050510.15252/msb.202110505 ↗
56. 10.1016/j.biomaterials.2010.11.04410.1016/j.biomaterials.2010.11.044 ↗
57. 10.1021/la026142j10.1021/la026142j ↗
58. 10.1111/boc.20180000610.1111/boc.201800006 ↗
59. 10.1038/s41598-019-40608-410.1038/s41598-019-40608-4 ↗
60. 10.7554/eLife.5191210.7554/eLife.51912 ↗
61. 10.1091/mbc.E18-05-031910.1091/mbc.E18-05-0319 ↗
62. 10.1038/ncomms1523710.1038/ncomms15237 ↗
63. 10.3389/fcell.2020.57522610.3389/fcell.2020.575226 ↗
64. 10.3389/fcell.2021.80966810.3389/fcell.2021.809668 ↗
65. 10.1016/j.bbamcr.2018.03.00410.1016/j.bbamcr.2018.03.004 ↗
66. 10.1016/j.celrep.2020.10807110.1016/j.celrep.2020.108071 ↗
67. 10.1038/nrc265710.1038/nrc2657 ↗
68. 10.1016/j.cell.2019.05.04110.1016/j.cell.2019.05.041 ↗
69. 10.1016/j.phrs.2023.10684110.1016/j.phrs.2023.106841 ↗
70. a)R.Kolde https://cran.r‐project.org/web/packages/pheatmap/index.html(accessed: 2012);
71. 10.1093/bioinformatics/btac75710.1093/bioinformatics/btac757 ↗
72. c)https://www.gsea‐msigdb.org/gsea/msigdb/human/geneset/HALLMARK_HYPOXIA.html.
73. 10.1007/s12195-021-00694-910.1007/s12195-021-00694-9 ↗
74. Oshi M. · Am. J. Cancer Res. · 2021 · 11 · 3070
75. 10.1038/s41568-019-0143-710.1038/s41568-019-0143-7 ↗
76. 10.1038/s41416-023-02408-610.1038/s41416-023-02408-6 ↗
77. 10.1083/jcb.20190800610.1083/jcb.201908006 ↗
78. 10.1186/s13578-020-00396-110.1186/s13578-020-00396-1 ↗
79. 10.3389/fonc.2020.60241610.3389/fonc.2020.602416 ↗
80. Tokumaru Y. · Am. J. Cancer Res. · 2020 · 10 · 897
81. 10.1038/s41571-022-00668-410.1038/s41571-022-00668-4 ↗
82. 10.1038/s41586-019-1526-310.1038/s41586-019-1526-3 ↗
83. 10.1038/s41467-017-01743-610.1038/s41467-017-01743-6 ↗
84. 10.1186/s12957-020-02075-410.1186/s12957-020-02075-4 ↗
85. 10.1038/oncsis.2016.7510.1038/oncsis.2016.75 ↗
86. 10.1158/0008-5472.CAN-13-074910.1158/0008-5472.CAN-13-0749 ↗
87. 10.1073/pnas.202650711810.1073/pnas.2026507118 ↗
88. 10.35772/ghm.2020.0108910.35772/ghm.2020.01089 ↗
89. 10.1073/pnas.201191211710.1073/pnas.2011912117 ↗
90. 10.1186/s13046-020-01588-w10.1186/s13046-020-01588-w ↗
91. 10.1021/acs.jpcb.1c0069410.1021/acs.jpcb.1c00694 ↗
92. Groysman L. · Am. J. Cancer Res. · 2021 · 11 · 6086
93. 10.1016/j.bj.2017.05.00110.1016/j.bj.2017.05.001 ↗
94. Fei F. · J. Exp. Clin. Cancer Res. · 2015 · 158 · 4152
95. 10.7554/eLife.2713410.7554/eLife.27134 ↗
96. 10.1186/s12885-022-09983-610.1186/s12885-022-09983-6 ↗
97. 10.2147/OTT.S19131710.2147/OTT.S191317 ↗
98. 10.1091/mbc.e09-05-041710.1091/mbc.e09-05-0417 ↗
99. 10.1016/j.celrep.2018.10.02410.1016/j.celrep.2018.10.024 ↗
100. 10.1016/j.colsurfb.2022.11247510.1016/j.colsurfb.2022.112475 ↗